IonQ, Inc.
IONQIonQ, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $130.0 million, up 201.9% from fiscal 2024.
- Revenue
- +336.0%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
After hours trading: 21.60, up 4.25%, last trade Fri 8:00pm Eastern.
Follow IONQ
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was −19.4% in Q3 FY26, against a low of −51.5% in Q2 FY26. ROE, at 6.98%, is far above it because equity is small against the capital the business uses.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | −24.3% | 11.4% | −60.4% | 7.0% |
| ROIC | −27.9% | −17.5% | −51.5% | −19.4% |
Debt
Net debt is 3.05× a year’s EBITDA. Debt is 0.01× equity.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.0× | 0.0× | 0.0× | 0.0× |
| Net debt / EBITDA | 12.2× | 8.9× | 7.3× | 3.1× |
Cash cycle, in days
Customers pay in 158 days and suppliers are paid in 88. Cash is tied up for 70 days between paying for goods and being paid.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Cash cycle | 64 | 77 | 63 | 70 |
| Days to pay suppliers | 123 | 114 | 93 | 88 |
| Days to be paid | 187 | 192 | 157 | 158 |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has grown 111.1%; book value has fallen 4.95%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 1.1× | 1.4× | 2.1× |
| Book value | 1.0× | 1.0× | 0.7× | 1.0× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 5 | 3 |
| (24.32%) | 11.37% | (60.37%) | 6.98% | ||
| (14.42%) | 8.68% | (33.57%) | 4.19% | ||
ROIC |
(27.86%) | (17.54%) | (51.52%) | (19.40%) | |
Return on Tangible Assets |
(20.10%) | 14.41% | (58.58%) | 12.55% | |
Average Days of Receivables |
186.78 | 191.55 | 156.84 | 158.38 | |
Free Cash Flow per Share |
(1.07) | (1.18) | (1.32) | (1.77) | |
Free Cash Flow |
(299.60) | (423.66) | (483.87) | (688.54) | |
Capital Expenditures |
(16.42) | (22.48) | (31.50) | (43.71) | |
| Other line items | |||||
Cash ROIC |
(4.83%) | (6.03%) | (8.86%) | (11.31%) | |
Accounts Receivable Turnover |
3.39 | 3.48 | 3.94 | 3.77 | |
Accounts Payable Turnover |
4.94 | 5.20 | 6.51 | 6.67 | |
Average Days of Payables |
123.12 | 114.21 | 93.39 | 87.95 | |
Tax Rate |
(0.08) | 0.19 | (0.03) | 2.44 | |
Research and Development Expense of Revenue |
235.13% | 209.22% | 182.07% | 137.77% | |
Selling, General and Administrative Expense of Revenue |
229.61% | 205.31% | 192.98% | 152.59% | |
Share Based Compensation of Revenue |
240.00% | 217.67% | 182.56% | 137.72% | |
Operating CF/Net income |
0.55 | (1.23) | 0.33 | (2.53) | |
Depreciation/Fixed assets |
0.61 | 0.83 | 1.01 | 0.29 | |
Capex/Depreciation |
(0.22) | (0.20) | (0.22) | (0.18) | |
Revenue per Share |
0.46 | 0.52 | 0.67 | 0.98 | |
Operating CF per Share |
(1.01) | (1.12) | (1.23) | (1.66) | |
Capex per Share |
(0.06) | (0.06) | (0.09) | (0.11) | |
Capex to Sales |
0.13 | 0.12 | 0.13 | 0.11 |